In diagnostics, while FABP1 combined with TRIB3 can improve the sensitivity of early gastric cancer diagnosis[34], and FABP6 combined with CEA can enhance CRC diagnostic efficacy[127], the specificity of single biomarkers and expression heterogeneity across different cancer types limit clinical application. Here, FABP6 is linked to gastric cancer.